First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings $27.47 -0.29 (-1.04%) As of 02:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Top 25 FTXH HoldingsRankCompanyCurrent PriceWeightShares Held1JNJJohnson & Johnson$175.19-0.9%7.98%6,9402PFEPfizer$24.77-1.2%7.20%43,3303ABBVAbbVie$207.33-0.4%7.17%5,4794MRKMerck & Co., Inc.$83.17-1.1%7.02%12,4145BMYBristol Myers Squibb$47.24-0.8%6.16%19,2086GILDGilead Sciences$112.96-0.8%3.91%5,0097VTRSViatris$10.31-1.1%3.90%62,0378AMGNAmgen$285.93-0.7%3.86%1,8599UTHRUnited Therapeutics$304.21-0.4%3.64%1,78910BIIBBiogen$134.11-1.6%3.57%4,075 Get the Latest News and Ratings for FTXH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 11ZTSZoetis$153.66-1.1%3.54%3,42412LLYEli Lilly and Company$734.34+0.0%3.25%62213JAZZJazz Pharmaceuticals$124.66+0.2%3.18%3,98914REGNRegeneron Pharmaceuticals$580.94-1.0%3.13%81915MEDPMedpace$472.14-0.3%2.67%87016CRLCharles River Laboratories International$162.94+0.1%2.43%1,98717ELANElanco Animal Health$18.47-0.1%2.31%23,41918ILMNIllumina$99.41-0.1%2.23%2,99619EXELExelixis$38.31-0.5%1.98%7,82120OGNOrganon & Co.$9.09-1.3%1.93%27,77521NBIXNeurocrine Biosciences$138.080.0%1.66%1,81122HALOHalozyme Therapeutics$72.68-0.7%1.47%3,63623BMRNBioMarin Pharmaceutical$58.15-0.9%1.12%2,81524PRGOPerrigo$23.78-0.4%1.00%5,20325ALKSAlkermes$29.17-0.3%0.94%5,110 Geographic ExposureUnited States94.5%Ireland5.0%Currency ExposureUSD92.7%Sector ExposureHealth Care98.8%Consumer Discretionary0.8%Industry ExposureBiotechnology77.3%Pharmaceuticals12.8%Diversified Consumer Services3.5%Health Care Equipment & Supplies3.2%Health Care Providers & Services2.1%Health Care Technology0.6%SubIndustry ExposureBiotechnology75.9%Pharmaceuticals13.3%Life Sciences Tools & Services5.9%Health Care Services2.1%Health Care Distributors0.6% Related Companies and Tools Related Companies Horizon Kinetics Medical ETF Portfolio Companies T. Rowe Price Health Care ETF Portfolio Companies JPMorgan Healthcare Leaders ETF Portfolio Companies ProShares UltraShort Nasdaq Biotechnology Portfolio Companies Invesco Nasdaq Biotechnology ETF Portfolio Companies Global X HealthTech ETF Portfolio Companies ProShares Ultra Nasdaq Biotechnology Portfolio Companies F/m Emerald Life Sciences Innovation ETF Portfolio Companies Invesco Dorsey Wright Healthcare Momentum ETF Portfolio Companies Invesco S&P SmallCap Health Care ETF Portfolio Companies This page (NASDAQ:FTXH) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access